UK Supreme Court Reworks Infringement Test In Eli Lilly Win
The U.K. Supreme Court explained Wednesday why it ruled in favor of Eli Lilly and Co. in a patent dispute with Actavis UK Ltd. over Lilly's top-selling cancer drug, Alimta, in...To view the full article, register now.
Already a subscriber? Click here to view full article